» Articles » PMID: 24335533

Progressive Neurodegeneration After Experimental Brain Trauma: Association with Chronic Microglial Activation

Overview
Specialties Neurology
Pathology
Date 2013 Dec 17
PMID 24335533
Citations 270
Authors
Affiliations
Soon will be listed here.
Abstract

Recent clinical studies indicate that traumatic brain injury (TBI) produces chronic and progressive neurodegenerative changes leading to late neurologic dysfunction, but little is known about the mechanisms underlying such changes. Microglial-mediated neuroinflammationis an important secondary injury mechanism after TBI. In human studies, microglial activation has been found to persist for many years after the initial brain trauma, particularly after moderate to severe TBI. In the present study, adult C57Bl/6 mice were subjected to single moderate-level controlled cortical impact and were followed up by longitudinal T2-weighted magnetic resonance imaging in combination with stereologic histologic assessment of lesion volume expansion, neuronal loss, and microglial activation for up to 1 year after TBI. Persistent microglial activation was observed in the injured cortex through 1 year after injury and was associated with progressive lesion expansion, hippocampal neurodegeneration, and loss of myelin. Notably, highly activated microglia that expressed major histocompatibility complex class II (CR3/43), CD68, and NADPH oxidase (NOX2) were detected at the margins of the expanding lesion at 1 year after injury; biochemical markers of neuroinflammation and oxidative stress were significantly elevated at this time point. These data support emerging clinical TBI findings and provide a mechanistic link between TBI-induced chronic microglial activation and progressive neurodegeneration.

Citing Articles

Diffuse Traumatic Brain Injury Induced Stimulator of Interferons (STING) Signaling in Microglia Drives Cortical Neuroinflammation, Neuronal Dysfunction, and Impaired Cognition.

Packer J, Giammo S, Wangler L, Davis A, Bray C, Godbout J Res Sq. 2025; .

PMID: 40034431 PMC: 11875282. DOI: 10.21203/rs.3.rs-5960640/v1.


The Dipeptidyl Peptidase-4 Inhibitor Saxagliptin as a Candidate Treatment for Disorders of Consciousness: A Deep Learning and Retrospective Clinical Analysis.

Toker D, Chiang J, Vespa P, Schnakers C, Monti M Neurocrit Care. 2025; .

PMID: 39904872 DOI: 10.1007/s12028-025-02217-0.


P2X7R antagonism suppresses long-lasting brain hyperexcitability following traumatic brain injury in mice.

Alves M, de Diego-Garcia L, Vegliante G, Moreno O, Gil B, Ramos-Cabrer P Theranostics. 2025; 15(4):1399-1419.

PMID: 39886340 PMC: 11780721. DOI: 10.7150/thno.97254.


Mitochondrial-targeted therapies in traumatic brain injury: From bench to bedside.

Tabassum S, Wu S, Lee C, Yang B, Gusdon A, Choi H Neurotherapeutics. 2024; 22(1):e00515.

PMID: 39721917 PMC: 11840356. DOI: 10.1016/j.neurot.2024.e00515.


Inflammatory Signaling Induces Mitochondrial Dysfunction and Neuronal Death in Traumatic Brain Injury via Downregulation of OXPHOS Genes.

Dong H, Zhang H, Cai L, Ye Q, Wang H, Liu B Biochem Genet. 2024; .

PMID: 39656403 DOI: 10.1007/s10528-024-10980-6.


References
1.
Surace M, Block M . Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci. 2012; 69(14):2409-27. PMC: 3677079. DOI: 10.1007/s00018-012-1015-4. View

2.
Ng K, Mikulis D, Glazer J, Kabani N, Till C, Greenberg G . Magnetic resonance imaging evidence of progression of subacute brain atrophy in moderate to severe traumatic brain injury. Arch Phys Med Rehabil. 2008; 89(12 Suppl):S35-44. DOI: 10.1016/j.apmr.2008.07.006. View

3.
Nonaka M, Chen X, Pierce J, Leoni M, McIntosh T, WOLF J . Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma. 1999; 16(11):1023-34. DOI: 10.1089/neu.1999.16.1023. View

4.
Loane D, Pocivavsek A, Moussa C, Thompson R, Matsuoka Y, Faden A . Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med. 2009; 15(4):377-9. PMC: 2844765. DOI: 10.1038/nm.1940. View

5.
Lynch M . The multifaceted profile of activated microglia. Mol Neurobiol. 2009; 40(2):139-56. DOI: 10.1007/s12035-009-8077-9. View